Atlas FDA

Lava Liquid Embolic System (Lava LES) and Lava Mixing Kit

FDA premarket approval P220020/S004 · decided 2025-03-20

Approval details

PMA number
P220020
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Lava Liquid Embolic System (Lava LES) and Lava Mixing Kit
Generic name
Embolization Agent, Vascular
Applicant
Sirtex Medical, Inc.
Date received
2025-02-18
Decision date
2025-03-20
Days to decision
30 days
Decision code
OK30
Product code
QVG
Advisory committee
Cardiovascular
Expedited review
No
Location
Woburn, MA
Statement
a change to acceptance criteria for air and liquid leak testing of the mixing manifold

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.